Vincent Chauvette, MD, Elbert E Williams, MD, Ismail El-Hamamsy, MD
In the past decade, the treatment of aortic regurgitation has evolved from a strategy focused mainly on valve replacement to one of valve repair (AVr). Nevertheless, AVr has yet to gain broad acceptance within the surgical community despite excellent reported results in selected centers. In fact, AVr failure due to recurrence of regurgitation remains a challenge. Thanks to sustained research efforts, the mechanisms underlying aortic valve repair failure are now better understood. The aim of this article is to discuss the risk factors for recurrent AR after valve repair, the technical strategies that can mitigate this risk and highlight the contemporary results associated with AVr.
Professor Ajit P. Yoganathan, PhD: "From bench to bedside": Celebrating his contributions to cardiac surgery with an honorary fellowship from the American Association for Thoracic SurgeryPedro Del Nido, MD, David H. Adams, MD
Surgical and Transcatheter Mitral Valve Replacement in Mitral Annular Calcification: A Systematic ReviewSophia Alexis, Aaqib Malik, Ahmed El‐Eshmawi, Isaac George, Aditya Sengupta, Susheel Kodali, Rebecca Hahn, Omar Khalique, Syed Zaid, Mayra Guerrero, Vinayak Bapat, Martin Leon, David H. Adams, and Gilbert Tang
- Vincent Chauvette, MD, Maral Ouzounian, MD, Jennifer Chung, MD, Mark Peterson, MD, Munir Boodhwani, MD, Ismail El-Hamamsy, MD, François Dagenais, MD, Matthew Valdis, MD, Michael W A Chu, MD
- Vincent Chauvette, MD, Elbert E Williams, MD, Ismail El-Hamamsy, MD